Dale Broadrick - 01 Mar 2022 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
10%+ Owner
Signature
/s/ Dale Broadrick
Issuer symbol
BRTX
Transactions as of
01 Mar 2022
Net transactions value
+$794,110
Form type
4
Filing time
29 Mar 2022, 16:52:15 UTC
Next filing
01 Apr 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BRTX Common Stock Purchase $12,598 +2,270 +1.1% $5.55 201,984 01 Mar 2022 See Footnote F1
transaction BRTX Common Stock Purchase $268,382 +47,840 +24% $5.61 249,824 02 Mar 2022 See Footnote F1, F2
transaction BRTX Common Stock Purchase $260,635 +47,648 +19% $5.47 297,472 03 Mar 2022 See Footnote F1, F3
transaction BRTX Common Stock Purchase $20,938 +3,800 +1.3% $5.51 301,272 04 Mar 2022 See Footnote F1
transaction BRTX Common Stock Purchase $108,057 +24,392 +16% $4.43 175,853 07 Mar 2022 Direct F4
transaction BRTX Common Stock Purchase $32,500 +8,125 +4.6% $4.00 183,978 08 Mar 2022 Direct
transaction BRTX Common Stock Purchase $47,500 +11,875 +6.5% $4.00 195,853 09 Mar 2022 Direct
transaction BRTX Common Stock Purchase $43,500 +10,000 +5.1% $4.35 205,853 21 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BRTX Warrant to acquire Common Stock 125 01 Mar 2022 Common Stock 125 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 125 01 Mar 2022 Common Stock 125 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 138 01 Mar 2022 Common Stock 138 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 138 01 Mar 2022 Common Stock 138 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 833 01 Mar 2022 Common Stock 833 $120.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Owned by Fleetco, Inc. of which reporting person is sole shareholder.
F2 This transaction was executed in multiple trades at prices ranging from $5.56 to $5.62 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
F3 This transaction was executed in multiple trades at prices ranging from $5.39 to $5.60 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
F4 This transaction was executed in multiple trades at prices ranging from $3.97 to $4.53 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.